{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T09:17:43Z","timestamp":1787995063088,"version":"build-2784847793"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ijcard.2016.04.027","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T06:30:43Z","timestamp":1460442643000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Bioresorbable scaffold \u2014 A magic bullet for the treatment of coronary artery disease?"],"prefix":"10.1016","volume":"215","author":[{"given":"Daniel","family":"Brie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Penson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Corina","family":"Serban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Simonton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6690-6874","authenticated-orcid":false,"given":"Maciej","family":"Banach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.04.027_bb0005","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/clc.22451","article-title":"The safety and efficacy of absorb bioresorbable vascular scaffold: A systematic review","volume":"39","author":"Lu","year":"2016","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0010","doi-asserted-by":"crossref","unstructured":"Gruentzig A. Results from coronary angioplasty and implications for the future. American heart journal.103(4):7e79\u201383.","DOI":"10.1016\/0002-8703(82)90486-0"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJM200101113440217","article-title":"The first patient to undergo coronary angioplasty \u2014 23-year follow-up","volume":"344","author":"Meier","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0735-1097(10)80111-1","article-title":"Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients","volume":"17","author":"Nobuyoshi","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0025","first-page":"327","article-title":"Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium","volume":"49","author":"AW","year":"1983","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0030","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-8703(94)90675-0","article-title":"Incidence, predictors, and management of acute coronary occlusion after coronary angioplasty","volume":"127","author":"de Feyter","year":"1994","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0035","first-page":"1311","article-title":"Endo-proth\u00e8ses coronariennes auto-expansives dans la pr\u00e9vention des rest\u00e9noses apr\u00e8s angioplastie transluminale","volume":"8","author":"Puel","year":"1987","journal-title":"Arch Mal Coeur"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.027_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease","volume":"331","author":"Serruys","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.027_bb0045","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease","volume":"331","author":"Fischman","year":"1994","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ijcard.2016.04.027_bb0050","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1053\/euhj.2001.2892","article-title":"Coronary restenosis elimination with a sirolimus eluting stent; first European human experience with 6-month angiographic and intravascular ultrasonic follow-up","volume":"22","author":"Rensing","year":"2001","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.ijcard.2016.04.027_bb0060","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","article-title":"In-stent restenosis in the drug-eluting stent era","volume":"56","author":"Dangas","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.027_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.12.019","article-title":"Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up","volume":"122","author":"Roukoz","year":"2009","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCINTERVENTIONS.110.959882","article-title":"Restenosis: delineating the numerous causes of drug-eluting stent restenosis","volume":"4","author":"Farooq","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0075","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcin.2013.06.015","article-title":"Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients","volume":"6","author":"Tada","year":"2013","journal-title":"JACC Cardiovascular interventions"},{"issue":"21","key":"10.1016\/j.ijcard.2016.04.027_bb0080","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2013.08.725","article-title":"Stent thrombosis with drug-eluting stents: is the paradigm shifting?","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ijcard.2016.04.027_bb0090","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/eht570","article-title":"Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis","volume":"35","author":"Kang","year":"2014","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.027_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078667","article-title":"Efficacy and safety of biodegradable polymer biolimus-eluting stents versus durable polymer drug-eluting stents: a meta-analysis","volume":"8","author":"Ye","year":"2013","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.ijcard.2016.04.027_bb0100","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"issue":"24","key":"10.1016\/j.ijcard.2016.04.027_bb0105","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1161\/01.CIR.0000078025.19258.28","article-title":"Drug-eluting stents: cost versus clinical benefit","volume":"107","author":"Lemos","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/clpt.2009.8","article-title":"A critical appraisal of the safety and efficacy of drug-eluting stents","volume":"85","author":"Maluenda","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"8b","key":"10.1016\/j.ijcard.2016.04.027_bb0115","article-title":"Drug-eluting stent safety","volume":"100","author":"Slottow","year":"2007","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0120","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ijcard.2016.04.027_bb0125","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.110.971606","article-title":"Bioresorbable scaffold: the advent of a new era in percutaneous coronary and peripheral revascularization?","volume":"123","author":"Onuma","year":"2011","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.ijcard.2016.04.027_bb0130","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","article-title":"Report of a European Society Of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12916-015-0459-4","article-title":"Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies","volume":"13","author":"Banach","year":"2015","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcin.2015.11.019","article-title":"The bioresorbable scaffold: will oversizing affect outcomes?","volume":"9","author":"Kawamoto","year":"2016","journal-title":"J Am Coll Cardiol Intv"},{"issue":"F","key":"10.1016\/j.ijcard.2016.04.027_bb0145","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.4244\/EIJV5IFA2","article-title":"Bioabsorbable polymers in medicine: an overview","volume":"5","author":"Vert","year":"2009","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0150","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/eurheartj\/ehr384","article-title":"From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?","volume":"33","author":"Serruys","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0155","doi-asserted-by":"crossref","first-page":"h1618","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0160","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/1755-5922.12137","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stents: meta-analysis of randomized trials","volume":"33","author":"Abo-Salem","year":"2015","journal-title":"Cardiovasc Ther"},{"issue":"13","key":"10.1016\/j.ijcard.2016.04.027_bb0165","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacc.2015.01.039","article-title":"Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials","volume":"65","author":"Giustino","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.027_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjca.2014.07.006","article-title":"Optimal duration of dual antiplatelet therapy after implantation of bioresorbable vascular scaffolds: lessons from optical coherence tomography","volume":"30","author":"Sato","year":"2014","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0175","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.atherosclerosis.2015.10.017","article-title":"Impact of carotid atherosclerosis loci on cardiovascular events","volume":"243","author":"Hemerich","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCINTERVENTIONS.109.859173","article-title":"Bioabsorbable coronary stents","volume":"2","author":"Ormiston","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.027_bb0185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/01.CIR.0000156462.97532.8F","article-title":"Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent","volume":"111","author":"Spuentrup","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0190","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ccd.20520","article-title":"First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby","volume":"66","author":"Zartner","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"issue":"Suppl. 5","key":"10.1016\/j.ijcard.2016.04.027_bb0195","article-title":"Bioabsorbable polymers in medicine: an overview","author":"Vert","year":"2009","journal-title":"EuroIntervention"},{"issue":"F","key":"10.1016\/j.ijcard.2016.04.027_bb0200","doi-asserted-by":"crossref","first-page":"F15","DOI":"10.4244\/EIJV5IFA3","article-title":"Design principles and performance of bioresorbable polymeric vascular scaffolds","volume":"5","author":"Oberhauser","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0205","doi-asserted-by":"crossref","unstructured":"Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. The Lancet.373(9667):897\u2013910.","DOI":"10.1016\/S0140-6736(09)60325-1"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0210","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jcin.2011.08.014","article-title":"Serial in vivo intravascular ultrasound-based echogenicity changes of everolimus-eluting bioresorbable vascular scaffold during the first 12months after implantationinsights from the ABSORB B trial","volume":"4","author":"Brugaletta","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ijcard.2016.04.027_bb0215","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.ijcard.2016.04.027_bb0220","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Onuma","year":"2010","journal-title":"Circulation"},{"issue":"Suppl. 8","key":"10.1016\/j.ijcard.2016.04.027_bb0225","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0235","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.atherosclerosis.2008.05.014","article-title":"Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study","volume":"202","author":"Takarada","year":"2009","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0240","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.12.008","article-title":"Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?","volume":"221","author":"Brugaletta","year":"2012","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0245","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/MCA.0b013e32836222ec","article-title":"Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation","volume":"24","author":"Yoneda","year":"2013","journal-title":"Coron Artery Dis"},{"issue":"32","key":"10.1016\/j.ijcard.2016.04.027_bb0250","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","article-title":"Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment","volume":"36","author":"Otsuka","year":"2015","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.027_bb0255","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/eurheartj\/ehs086","article-title":"Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials","volume":"33","author":"Stefanini","year":"2012","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.027_bb0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcin.2013.04.011","volume":"6","author":"Serruys","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.ijcard.2016.04.027_bb0265","doi-asserted-by":"crossref","first-page":"833","DOI":"10.4244\/EIJV10I7A143","article-title":"Vascular healing and integration of a fully bioresorbable everolimus-eluting scaffold in a rabbit iliac arterial model","volume":"10","author":"Vorpahl","year":"2014","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0270","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCINTERVENTIONS.113.000990","article-title":"Long-term safety of an everolimus-eluting bioresorbable vascular scaffold and the cobalt\u2013chromium XIENCE V stent in a porcine coronary artery model","volume":"7","author":"Otsuka","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.027_bb0275","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002551","article-title":"Coronary artery vessel healing pattern, short and long term, after implantation of the everolimus\u2010eluting bioresorbable vascular scaffold","volume":"4","author":"Kraak","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.ijcard.2016.04.027_bb0280","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/CIRCULATIONAHA.109.921528","volume":"122","author":"Onuma","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0285","doi-asserted-by":"crossref","unstructured":"Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MWI, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. The Lancet.371(9616):899\u2013907.","DOI":"10.1016\/S0140-6736(08)60415-8"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0290","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.12.008","article-title":"Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?","volume":"221","author":"Brugaletta","year":"2012","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0295","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ccd.21136","article-title":"Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials","volume":"70","author":"Tanimoto","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ccd.22864","article-title":"Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent","volume":"78","author":"Onuma","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.ijcard.2016.04.027_bb0305","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1161\/CIRCULATIONAHA105.570093","article-title":"Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials","volume":"112","author":"Mauri","year":"2005","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.ijcard.2016.04.027_bb0310","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","article-title":"Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison","volume":"111","author":"Mauri","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0315","first-page":"409","article-title":"Bioresorbable scaffolds for percutaneous coronary interventions","volume":"2014","author":"Gogas","year":"2014","journal-title":"Global Cardiol Sci Pract"},{"issue":"15","key":"10.1016\/j.ijcard.2016.04.027_bb0320","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0325","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","article-title":"First serial assessment at 6months and 2years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study","volume":"5","author":"Ormiston","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.027_bb0330","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV10I6A118","article-title":"Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial","volume":"10","author":"Zhang","year":"2014","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0335","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/eurheartj\/ehi571","article-title":"Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation","volume":"27","author":"Hofma","year":"2006","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0340","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1253\/circj.71.220","article-title":"Impaired endothelial vasomotor function after sirolimus-eluting stent implantation","volume":"71","author":"Fuke","year":"2007","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0345","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jacc.2005.01.062","article-title":"Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction","volume":"46","author":"Togni","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0350","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2006.09.021","article-title":"Local vascular dysfunction after coronary paclitaxel-eluting stent implantation","volume":"120","author":"Togni","year":"2007","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0355","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12265-014-9568-2","article-title":"Coronary vasomotion one year after drug-eluting stent implantation: comparison of everolimus-eluting and paclitaxel-eluting coronary stents","volume":"7","author":"Hamilos","year":"2014","journal-title":"J Cardiovasc Transl Res"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0360","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijcard.2012.03.084","article-title":"Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature","volume":"165","author":"Minami","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.027_bb0365","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1536\/ihj.49.639","article-title":"Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9month comparison between zotarolimus-eluting and sirolimus-eluting stents","volume":"49","author":"Shin","year":"2008","journal-title":"Int Heart J"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.027_bb0370","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehr466","volume":"33","author":"Brugaletta","year":"2012","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.027_bb0375","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jcin.2013.11.024","article-title":"Lumen gain and restoration of pulsatility after implantation of a bioresorbable vascular scaffold in porcine coronary arteries","volume":"7","author":"Lane","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"issue":"9667","key":"10.1016\/j.ijcard.2016.04.027_bb0380","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0140-6736(09)60325-1","article-title":"A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods","volume":"373","author":"Serruys","year":"2009","journal-title":"Lancet (Lond, Eng)"},{"issue":"15","key":"10.1016\/j.ijcard.2016.04.027_bb0385","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.jacc.2011.05.050","article-title":"Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes","volume":"58","author":"Serruys","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"13s1","key":"10.1016\/j.ijcard.2016.04.027_bb0390","article-title":"Evaluation of the absorb everolimus eluting bioresorbable vascular scaffold (ABSORB BVS) in the treatment of patients with de novo native coronary artery lesions: 2year clinical results of ABSORB COHORT B trial","volume":"59","author":"Dudek","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.027_bb0395","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"10_S","key":"10.1016\/j.ijcard.2016.04.027_bb0400","article-title":"The ABSORB COHORT B trial: insights from longitudinal imaging follow-up from six months to three years","volume":"61","author":"Windecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0405","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCINTERVENTIONS.112.971549","article-title":"First serial assessment at 6months and 2years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study","volume":"5","author":"Ormiston","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"issue":"11_S","key":"10.1016\/j.ijcard.2016.04.027_bb0410","article-title":"TCT-619 ABSORB cohort B trial: five year angiographic results of the ABSORB everolimus eluting bioresorbable vascular scaffold","volume":"64","author":"De Bruyne","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0415","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled","volume":"10","author":"Abizaid","year":"2015","journal-title":"EuroIntervention"},{"issue":"9962","key":"10.1016\/j.ijcard.2016.04.027_bb0420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet (Lond, Engl)"},{"issue":"20","key":"10.1016\/j.ijcard.2016.04.027_bb0425","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0430","first-page":"283","article-title":"\u201cLeaving nothing behind\u201d: is the bioresorbable vascular scaffold a new hope for patients with coronary artery disease?","volume":"Vol. 10(4)","author":"Lesiak","year":"2014"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0435","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0440","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MCA.0000000000000109","article-title":"Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis","volume":"25","author":"Li","year":"2014","journal-title":"Coron Artery Dis"},{"issue":"47","key":"10.1016\/j.ijcard.2016.04.027_bb0445","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.ijcard.2016.04.027_bb0450","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ijcard.2016.04.027_bb0455","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ijcard.2016.04.027_bb0460","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcin.2014.01.165","article-title":"ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance","volume":"7","author":"Mattesini","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.027_bb0465","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0470","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jcin.2015.10.042","article-title":"1-Year outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: a propensity-matched comparison of the GHOST-EU and XIENCE V USA registries","volume":"9","author":"Tamburino","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.ijcard.2016.04.027_bb0475","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry","volume":"10","author":"Kraak","year":"2015","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0480","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJY14M12_10","article-title":"Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds","volume":"11","author":"Wohrle","year":"2015","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.ijcard.2016.04.027_bb0485","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.carrev.2015.05.010","article-title":"Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the absorb BVS: study design","volume":"16","author":"Cortese","year":"2015","journal-title":"Cardiovasc Revasc Med"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0490","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cjca.2014.12.001","article-title":"Procedural feasibility and clinical outcomes in propensity-matched patients treated with bioresorbable scaffolds vs new-generation drug-eluting stents","volume":"31","author":"Sato","year":"2015","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0495","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1002\/ccd.25569","article-title":"Comparison of early clinical outcomes between ABSORB bioresorbable vascular scaffold and everolimus-eluting stent implantation in a real-world population","volume":"85","author":"Costopoulos","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0500","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.carrev.2015.09.002","article-title":"Evaluation of the short- and long-term safety and therapy outcomes of the everolimus-eluting bioresorbable vascular scaffold system in patients with coronary artery stenosis: rationale and design of the German-Austrian ABSORB RegIstRy (GABI-R)","volume":"17","author":"Nef","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"issue":"15_S","key":"10.1016\/j.ijcard.2016.04.027_bb0505","article-title":"TCT-544 bioresorbable coronary devices in clinical practice: immediate and 30-day results of the prospective REPARA registry","volume":"66","author":"Hernandez","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"15_S","key":"10.1016\/j.ijcard.2016.04.027_bb0510","article-title":"TCT-14 ABSORB FIRST: 1-year clinical outcomes from a prospective, multi-center, global, real-world registry","volume":"66","author":"Seth","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0515","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/eurheartj\/eht546","article-title":"Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study","volume":"35","author":"Diletti","year":"2014","journal-title":"Eur Heart J"},{"issue":"1 Pt B","key":"10.1016\/j.ijcard.2016.04.027_bb0520","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","volume":"8","author":"Brugaletta","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0525","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.amjcard.2015.05.049","article-title":"Clinical comparison with short-term follow-up of bioresorbable vascular scaffold versus everolimus-eluting stent in primary percutaneous coronary interventions","volume":"116","author":"Cortese","year":"2015","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0530","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/eurheartj\/eht545","article-title":"Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study \u2018Prague 19\u2019","volume":"35","author":"Ko\u010dka","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0535","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1253\/circj.CJ-14-1398","article-title":"ST-segment elevation myocardial infarction \u2014 ideal scenario for bioresorbable vascular scaffold implantation?","volume":"79","author":"Scalone","year":"2015","journal-title":"Circ J"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0540","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction\u2014TROFI II trial","volume":"37","author":"Sabat\u00e9","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0545","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4244\/EIJY14M10_11","article-title":"Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre \u201cRegistro ABSORB Italiano\u201d (RAI registry)","volume":"11","author":"Ielasi","year":"2015","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0550","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jcin.2013.07.013","article-title":"The absorb bioresorbable vascular scaffold in coronary BifurcationsInsights from Bench testing","volume":"7","author":"D\u017eav\u00edk","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"issue":"3","key":"10.1016\/j.ijcard.2016.04.027_bb0555","first-page":"229","article-title":"Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds","volume":"62","author":"Capranzano","year":"2014","journal-title":"Minerva Cardioangiol"},{"issue":"V","key":"10.1016\/j.ijcard.2016.04.027_bb0560","doi-asserted-by":"crossref","DOI":"10.4244\/EIJV11SVA41","article-title":"Lessons from the GHOST-EU registry","volume":"11","author":"Latib","year":"2015","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0565","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ccd.26045","article-title":"Clinical outcomes following bioresorbable scaffold implantation for bifurcation lesions: overall outcomes and comparison between provisional and planned double stenting strategy","volume":"86","author":"Kawamoto","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0570","doi-asserted-by":"crossref","DOI":"10.4244\/EIJY15M09_10","article-title":"Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry","volume":"11","author":"Gori","year":"2015","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0575","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4244\/EIJY14M12_07","article-title":"Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study","volume":"11","author":"Vaquerizo","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2016.04.027_bb0580","doi-asserted-by":"crossref","unstructured":"Wiebe J, Liebetrau C, D\u00f6rr O, Most A, Weipert K, Rixe J, et al. Feasibility of everolimus-eluting bioresorbable vascular scaffolds in patients with chronic total occlusion. International journal of cardiology.179:90\u20134.","DOI":"10.1016\/j.ijcard.2014.10.032"},{"issue":"10018","key":"10.1016\/j.ijcard.2016.04.027_bb0585","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0590","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcin.2015.09.024","article-title":"Scaffold thrombosis after percutaneous coronary intervention with ABSORB bioresorbable vascular scaffold: a systematic review and meta-analysis","volume":"9","author":"Lipinski","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"10.1016\/j.ijcard.2016.04.027_bb0595","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.ijcard.2016.04.027_bb0600","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0605","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/CIRCINTERVENTIONS.109.882670","article-title":"The SYNTAX trial: a perspective","volume":"2","author":"Gulati","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.ijcard.2016.04.027_bb0610","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ijcard.2016.04.027_bb0615","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.CIR.0000143379.26342.5C","article-title":"Medical costs and quality of life 10 to 12years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease","volume":"110","author":"Hlatky","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0620","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.plipres.2012.03.003","article-title":"Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?","volume":"51","author":"Otocka-Kmiecik","year":"2012","journal-title":"Prog Lipid Res"},{"issue":"25","key":"10.1016\/j.ijcard.2016.04.027_bb0625","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.2174\/0929867321666140414103455","article-title":"Subfractions and subpopulations of HDL: an update","volume":"21","author":"Rizzo","year":"2014","journal-title":"Curr Med Chem"},{"issue":"1","key":"10.1016\/j.ijcard.2016.04.027_bb0630","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","article-title":"Endocan: a novel inflammatory indicator in cardiovascular disease?","volume":"243","author":"Balta","year":"2015","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.ijcard.2016.04.027_bb0635","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11255-014-0657-6","article-title":"Lipid, blood pressure and kidney update 2013","volume":"46","author":"Banach","year":"2014","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.ijcard.2016.04.027_bb0640","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.ijcard.2016.04.027_bb0645","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/eurheartj\/eht542","article-title":"Bioresorbable scaffolds: rationale, current status, challenges, and future","volume":"35","author":"Iqbal","year":"2014","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ijcard.2016.04.027_bb0650","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1093\/eurheartj\/ehr503","article-title":"A further step towards vascular reparative therapy","volume":"33","author":"Corti","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0655","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.77.2.361","article-title":"Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4months","volume":"77","author":"Serruys","year":"1988","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2016.04.027_bb0660","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/01.CIR.96.2.475","article-title":"Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy","volume":"96","author":"Kimura","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.04.027_bb9000","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: A systematic review and meta-analysis","author":"Banach","year":"2016","journal-title":"EuroIntervention"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316307148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316307148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T08:48:19Z","timestamp":1716022099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316307148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":133,"alternative-id":["S0167527316307148"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.027","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioresorbable scaffold \u2014 A magic bullet for the treatment of coronary artery disease?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}